Literature DB >> 18025509

Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT.

Darren D D Brennan1, Giulia A Zamboni, Vassilios D Raptopoulos, Jonathan B Kruskal.   

Abstract

Pancreatic adenocarcinoma is a common gastrointestinal malignancy that has a poor prognosis and for which successful surgical resection is the only method of cure. Preoperative staging and assessment can be performed with a number of modalities. Multidetector (64-section) volumetric computed tomography (CT) allows rapid anatomic coverage coupled with excellent spatial resolution. Understanding the technical parameters necessary for successful pancreatic CT angiography is crucial. Carefully timed scan acquisition maximizes the difference in attenuation between the neoplasm and the pancreatic parenchyma and allows accurate local and distant staging as well as assessment of local resectability. In addition, angiographic data sets can be rendered to create displays of the local venous and arterial anatomy that are familiar to surgeons. Advanced rendering can also be used to create pancreaticographic type images. The TNM system of staging for pancreatic adenocarcinoma is not frequently included in radiology reporting but is important for deciding on optimal therapy and neoadjuvant therapy. RSNA, 2007

Entities:  

Mesh:

Year:  2007        PMID: 18025509     DOI: 10.1148/rg.276075034

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  30 in total

1.  Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer.

Authors:  Kunihiko Izuishi; Yuka Yamamoto; Takanori Sano; Ryusuke Takebayashi; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  J Gastrointest Surg       Date:  2010-05-05       Impact factor: 3.452

Review 2.  Current status and progress of pancreatic cancer in China.

Authors:  Quan-Jun Lin; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 3.  Radiology of pancreatic neoplasms: An update.

Authors:  Luis Gijón de la Santa; José Antonio Pérez Retortillo; Ainhoa Camarero Miguel; Lea Marie Klein
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

4.  Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.

Authors:  Giovanni Marchegiani; Valentina Todaro; Enrico Boninsegna; Riccardo Negrelli; Binit Sureka; Debora Bonamini; Roberto Salvia; Riccardo Manfredi; Roberto Pozzi Mucelli; Claudio Bassi
Journal:  Eur Radiol       Date:  2018-04-20       Impact factor: 5.315

5.  Risk factors for pancreatic adenocarcinoma and prospects for screening.

Authors:  G Anton Decker; Mashal J Batheja; Joseph M Collins; Alvin C Silva; Kristin L Mekeel; Adyr A Moss; Cuong C Nguyen; Douglas F Lake; Laurence J Miller
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

6.  Differential diagnosis of pancreatic cancer from other solid tumours arising from the periampullary area on MDCT.

Authors:  Suk Ki Jang; Jung Hoon Kim; Ijin Joo; Ju Hyun Jeon; Kyung Sook Shin; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

Review 7.  Staging cancer of the pancreas.

Authors:  G Morana; L Cancian; R Pozzi Mucelli; C Cugini
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

8.  Surgical resectability of pancreatic adenocarcinoma: CTA.

Authors:  Jimmie C Wong; Steven Raman
Journal:  Abdom Imaging       Date:  2009-05-26

Review 9.  Strategies for early detection of resectable pancreatic cancer.

Authors:  Keiichi Okano; Yasuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility.

Authors:  Soo Jin Kim; Byung Ihn Choi; Se Hyung Kim; Jae Young Lee
Journal:  Indian J Radiol Imaging       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.